These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4176628)

  • 21. Trophic functions of the neuron. IV. Clinical disorders of trophic function: muscular dystrophy? Are the muscular dystrophies neurogenic?
    Rowland LP
    Ann N Y Acad Sci; 1974 Mar; 228(0):244-60. PubMed ID: 4526279
    [No Abstract]   [Full Text] [Related]  

  • 22. [Chronic progressive external ophthalmoplegia in the current views of isolated and evolutive ocular myopathy. Diagnostic and prognostic judgment by means of electromyography and determination of muscle enzymes in the blood].
    Morra M
    Minerva Oftalmol; 1970; 12(2):47-58. PubMed ID: 5507455
    [No Abstract]   [Full Text] [Related]  

  • 23. Quantitative strength measurements in muscular dystrophy.
    Fowler WM; Gardner GW
    Arch Phys Med Rehabil; 1967 Dec; 48(12):629-44. PubMed ID: 6073414
    [No Abstract]   [Full Text] [Related]  

  • 24. [Electrocardiographic study of progressive muscular dystrophy Duchenne's type].
    De los Arcos E; Sánchez Cascos A; De Rábago P
    Rev Esp Cardiol; 1969; 22(2):193-200. PubMed ID: 5801957
    [No Abstract]   [Full Text] [Related]  

  • 25. [Aldolase activity of the blood in patients with progressive muscular dystrophy].
    BERGAMI PL; ZANOLI S
    Chir Organi Mov; 1959; 47():430-4. PubMed ID: 13799247
    [No Abstract]   [Full Text] [Related]  

  • 26. [Enzymatic activity of the serum in the family of a progressive muscular dystrophy patient].
    Esaki K; Tokoro T; Yamamoto K; Kato T; Asano B
    Iryo; 1969 Oct; 23(10):1306-11. PubMed ID: 5364982
    [No Abstract]   [Full Text] [Related]  

  • 27. Studies of enzymes in serum in muscular dystrophy. II. Diagnostic and prognostic significance in relatives of dystrophic persons.
    PEARSON CM; CHOWDHURY SR; FOWLER WM; JONES MH; GRIFFITH WH
    Pediatrics; 1961 Dec; 28():962-70. PubMed ID: 14484758
    [No Abstract]   [Full Text] [Related]  

  • 28. [The treatment of progressive muscular dystrophy with nucleosides and nucleotides. Clinical and serologic findings (aldolase and creatinphosphokinase)].
    Ceccarelli A; Leone P; Moretti A
    Clin Pediatr (Bologna); 1967 Sep; 49(9):468-75. PubMed ID: 5608288
    [No Abstract]   [Full Text] [Related]  

  • 29. [Serum aldolase and glutamic oxalaxetic transaminase in the evaluation of the involvement of skeletal muscles].
    Schaposnik F; Laguens R; Salvioli MV; Neumann M; Cacciatore J
    Prensa Med Argent; 1970 May; 57(10):476-9. PubMed ID: 5452220
    [No Abstract]   [Full Text] [Related]  

  • 30. Duchenne's muscular dystrophy: carrier detection by muscle ultrasound.
    Rott HD; Mulz D
    J Genet Hum; 1983 Mar; 31(1):63-5. PubMed ID: 6619807
    [No Abstract]   [Full Text] [Related]  

  • 31. [Evaluation of fine neuromuscular control in Duchenne's progressive muscular dystrophy I. A basic and clinical study in the rehabilitation of 10 non-ambulatory patients].
    Simard T
    Union Med Can; 1982 Jun; 111(6):569-74. PubMed ID: 7112753
    [No Abstract]   [Full Text] [Related]  

  • 32. [Characterization, by chromatography on DEAE-sephadex, of fructose-1,6-diphosphate aldolase of normal adult and fetal muscle and muscle of subjects with progressive muscular dystrophy of the Duchenne type].
    Idéo G; Cao A
    Boll Soc Ital Biol Sper; 1966 Jun; 42(11):693-6. PubMed ID: 5967932
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparative electromyographic study in atrophic, hypertrophic and distal muscles in Duchenne's muscular dystrophy.
    Singh N; Bhatia HK; Singh B; Chhina GS
    Electromyogr Clin Neurophysiol; 1976; 16(4):353-63. PubMed ID: 1001238
    [No Abstract]   [Full Text] [Related]  

  • 34. [Case of progressive myocardiopathy in Duchenne's muscular dystrophy].
    Effremushkin GG; Safir DI; Afinogenov VI; Iakovlev VV
    Ter Arkh; 1980; 52(7):133-4. PubMed ID: 6447380
    [No Abstract]   [Full Text] [Related]  

  • 35. [Modifications of contractile kinetics in Duchenne's muscular dystrophy].
    Desmedt JE; Emeryk B; Renoirte P; Hainaut K
    Rev Neurol (Paris); 1968 Jun; 118(6):534-5. PubMed ID: 5724663
    [No Abstract]   [Full Text] [Related]  

  • 36. [The 1st reproducible remissions in the evolution of Duchenne's muscular dystrophy].
    Rideau Y; Duport G; Delaubier A
    Bull Acad Natl Med; 1986 May; 170(5):605-10. PubMed ID: 3536021
    [No Abstract]   [Full Text] [Related]  

  • 37. [Muscular dystrophies].
    Zellweger H; Ionasescu V; Conway TW
    Schweiz Med Wochenschr; 1972 Jun; 102(22):753-9. PubMed ID: 5035931
    [No Abstract]   [Full Text] [Related]  

  • 38. [Duchenne's muscular dystrophy. Report of a clinical case].
    Weiller C
    Pathologe; 1985 Jan; 6(1):32-7. PubMed ID: 3983086
    [No Abstract]   [Full Text] [Related]  

  • 39. [Letter: The neurogen theory of Duchenne's disease].
    Serratrice G; Gastaut JL
    Nouv Presse Med; 1975 Mar; 4(11):807 (2). PubMed ID: 1129053
    [No Abstract]   [Full Text] [Related]  

  • 40. [The selectivity of myopathic involvement in Duchenne's muscular dystrophy].
    Millefiorini M; Cortesani F
    Riv Neurol; 1981; 51(6):376-8. PubMed ID: 7336091
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.